EV/EBITDA:
-34.41-1.39(-4.21%)Summary
- As of today, TARS EV/EBITDA is -34.41, with a fall of -1.39 (-4.21%) during the most recent trading session on November 18, 2025.
- Over the past year, TARS EV/EBITDA has dropped by -22.22 (-182.28%).
- TARS EV/EBITDA is now -1586.76% below its all-time high of -2.04.
Performance
TARS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TARS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -4.2% | +4.2% | +3.8% |
| 1M1 Month | -6.2% | +6.2% | +5.5% |
| 3M3 Months | -43.5% | +50.5% | +43.3% |
| 6M6 Months | -110.1% | +89.5% | +71.0% |
| YTDYTD | -93.1% | +54.8% | +39.0% |
| 1Y1 Year | -182.3% | +90.5% | +64.2% |
| 5Y5 Years | -55.8% | +707.4% | +228.9% |
TARS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -29.00 | -18.7% | -34.41 | at low |
| 3M | 3-Month | -21.72 | -58.4% | -34.41 | at low |
| 6M | 6-Month | -13.91 | -147.4% | -34.41 | at low |
| 1Y | 1-Year | -12.04 | -199.0% | -34.41 | at low |
| 3Y | 3-Year | -2.04 | -1586.8% | -34.41 | at low |
| 5Y | 5-Year | -2.04 | -1586.8% | -126.17 | +72.7% |
| All-Time | All-Time | -2.04 | -1586.8% | -126.17 | +72.7% |
TARS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -34.41(-93.1%) |
| 2024 | -17.82(-372.7%) |
| 2023 | -3.77(-15.3%) |
| Date | Value |
|---|---|
| 2022 | -3.27(+86.1%) |
| 2021 | -23.56(+5.8%) |
| 2020 | -25.00 |
FAQ
- What is Tarsus Pharmaceuticals, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Tarsus Pharmaceuticals, Inc.?
- What is TARS EV/EBITDA year-to-date change?
- What is Tarsus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Tarsus Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of TARS is -34.41
What is the all-time high EV/EBITDA for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high EV/EBITDA is -2.04
What is TARS EV/EBITDA year-to-date change?
Tarsus Pharmaceuticals, Inc. EV/EBITDA has changed by -16.59 (-93.10%) since the beginning of the year
What is Tarsus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, TARS EV/EBITDA has changed by -22.22 (-182.28%)